Candidate epitopes for measurement of hCG and related molecules: The second ISOBM TD-7 workshop

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 4033-4057

  Berger, P ^a   Paus, E ^b   Hemken, P M ^c   Sturgeon, C ^d   Stewart, W W ^e   Skinner, J P ^c   Harwick, L C ^c   Saldana, S C ^c   Ramsay, C S ^c   Rupprecht, K R ^c   Olsen, K H ^b   Bidart, J M ^f   Stenman, U H ^g  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ABBOTT DIAGNOSTICS   (United States)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e NINEWELLS HOSPITAL   (United Kingdom)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antibody standardization; Epitope standardization; hCG IRR; hCG variants measurement; International standards for hCG

Indexed keywords

CHORIONIC GONADOTROPIN ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT; CHORIONIC GONADOTROPIN DERIVATIVE; EPITOPE; HCG BETA CF; HCG BETA N; HCG N; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DEGLYCOSYLATION; EPITOPE MAPPING; GEL PERMEATION CHROMATOGRAPHY; IODINATION; ISOELECTRIC FOCUSING; LIGHT CHAIN; PRIORITY JOURNAL;

EID: 84888349473     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0994-6     Document Type: Article

References (72)

1. Berger P, Sturgeon C, Bidart JM, Paus E, Gerth R, Niang M, et al. The isobm td-7 workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis:assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumor Biol. 2002;23:1-38.
2. Stenman UH, Alfthan H, Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem. 2004;37:549-61.
3. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature. 1994;369:455-61.
4. Talmadge K, Boorstein WR, Fiddes JC. The human genome contains seven genes for the beta-subunit of chorionic gonadotropin but only one gene for the beta-subunit of luteinizing hormone. DNA. 1983;2:281-9.
5. Fiddes JC, Goodman HM. The cdna for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3′-untranslated region. Nature. 1980;286:684-7.
6. Sturgeon CM, Berger P, Bidart JM, Birken S, Burns C, Norman RJ, et al. Differences in recognition of the 1st who international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem. 2009;55:1484-91.
7. Fiddes JC, Goodman HM. Isolation, cloning and sequence analysis of the cDNA for the alpha-subunit of human chorionic gonadotropin. Nature. 1979;281:351-6.
8. Stenman UH, Bidart JM, Birken S, Mann K, Nisula B, O'Connor J. Standardization of protein immunoprocedures. Choriogonadotropin (cg). Scand J Clin Lab Invest Suppl. 1993;216:42-78.
9. Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, et al. Preparation and characterization of new who reference reagents for human chorionic gonadotropin and metabolites. Clin Chem. 2003;49:144-54.
10. Merz WE, Krause JM, Roig J, Singh V, Berger P. Nonassembled human chorionic gonadotropin subunits and {alpha}{alpha}-homodimers use fast-track processing in the secretory pathway in contrast to {alpha}{beta}-heterodimers. Endocrinology. 2007;148:5831-41.
11. Valmu L, Alfthan H, Hotakainen K, Birken S, Stenman UH. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry. Glycobiology. 2006;16:1207-18.
12. Toll H, Berger P, Hofmann A, Hildebrandt A, Oberacher H, Lenhof HP, et al. Glycosylation patterns of human chorionic gonadotropin revealed by liquid chromatography-mass spectrometry and bioinformatics. Electrophoresis. 2006;27:2734-46.
13. Wide L, Lee JY, Rasmussen C. A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation. J Clin Endocrinol Metab. 1994;78:1419-23.
14. Lopata A, Oliva K, Stanton PG, Robertson DM. Analysis of chorionic gonadotrophin secreted by cultured human blastocysts. Mol Hum Reprod. 1997;3:517-21.
15. Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol. 2002;172:497-506.
16. Mann K, Schneider N, Hoermann R. Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Endocrinology. 1986;118:1558-66.
17. Berger P, Schwarz S, Spottl G, Wick G, Mann K. Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies. J Clin Endocrinol Metab. 1993;77:347-51.
18. Lottersberger C, Hoermann R, Mann K, Schwarz S, Berger P. Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: biological and diagnostic relevance. Horm Res. 2003;59:125-34.
19. Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine. 1997;7:15-32.
20. Birken S. Specific measurement of o-linked core 2 sugar-containing isoforms of hyperglycosylated human chorionic gonadotropin by antibody b152. Tumour Biol. 2005;26:131-41.
21. Bidart JM, Birken S, Berger P, Krichevsky A. Immunochemical mapping of hCG and hCG-related molecules. Scand J Clin Lab Invest Suppl. 1993;216:118-36.
22. Berger P, Bidart JM, Delves PS, Dirnhofer S, Hoermann R, Isaacs N, et al. Immunochemical mapping of gonadotropins. Mol Cell Endocrinol. 1996;125:33-43.
23. Bidart JM, Troalen F, Bohuon CJ, Hennen G, Bellet DH. Immunochemical mapping of a specific domain on human choriogonadotropin using anti-protein and anti-peptide monoclonal antibodies. J Biol Chem. 1987;262:15483-9.
24. Dirnhofer S, Madersbacher S, Bidart JM, Ten Kortenaar PB, Spottl G, Mann K, et al. The molecular basis for epitopes on the free beta-subunit of human chorionic gonadotrophin (hCG), its carboxyl-terminal peptide and the hCG beta-core fragment. J Endocrinol. 1994;141:153-62.
25. Kofler R, Kalchschmid E, Berger P, Wick G. Production and characterization of monoclonal antibodies against bovine luteinizing hormone. Immunobiology. 1981;160:196-207.
26. Kofler R, Berger P, Wick G. Monoclonal antibodies against human chorionic gonadotropin (hCG): I. Production, specificity, and intramolecular binding sites. Am J Reprod Immunol. 1982;2:212-6.
27. Stahli C, Miggiano V, Stocker J, Staehelin T, Haring P, Takacs B. Distinction of epitopes by monoclonal antibodies. Methods Enzymol. 1983;92:242-53.
28. Berger P. molecular morphology of placental and pituitary hormones: epitope mapping with monoclonal antibodies. Wien Klin Wochenschr. 1985;97:573-81.
29. Bidart JM, Bellet DH, Alberici GF, Van Besien F, Bohuon C. The immune response to a synthetic peptide analogous to the 109-145 beta hCG carboxyl-terminus is directed against two major and two minor regions. Mol Immunol. 1987;24:339-45.
30. Berger P, Panmoung W, Khaschabi D, Mayregger B, Wick G. Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiomometric assay. Endocrinology. 1988;123:2351-9.
31. Berger P, Klieber R, Panmoung W, Madersbacher S, Wolf H, Wick G. Monoclonal antibodies against the free subunits of human chorionic gonadotrophin. J Endocrinol. 1990;125:301-9.
32. Bidart JM, Ozturk M, Bellet DH, Jolivet M, Gras-Masse H, Troalen F, et al. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide. J Immunol. 1985;134:457-64.
33. Bristow A, Berger P, Bidart JM, Birken S, Norman R, Stenman UH, et al. Establishment, value assignment, and characterization of new who reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem. 2005;51:177-82.
34. Tsai PK, Bruner MW, Irwin JI, Ip CC, Oliver CN, Nelson RW, et al. Origin of the isoelectric heterogeneity of monoclonal immunoglobulin h1b4. Pharm Res. 1993;10:1580-6.
35. Perkins M, Theiler R, Lunte S, Jeschke M. Determination of the origin of charge heterogeneity in a murine monoclonal antibody. Pharm Res. 2000;17:1110-7.
36. Madersbacher S, Berger P. Antibodies and immunoassays. Methods. 2000;21:41-50.
37. Dirnhofer S, Lechner O, Madersbacher S, Klieber R, de Leeuw R, Wick G, et al. Free alpha subunit of human chorionic gonadotrophin: Molecular basis of immunologically and biologically active domains. J Endocrinol. 1994;140:145-54.
38. Schwarz S, Berger P, Wick G. The antigenic surface of human chorionic gonadotropin as mapped by murine monoclonal antibodies. Endocrinology. 1986;118:189-97.
39. Birken S, Krichevsky A, O'Connor J, Schlatterer J, Cole L, Kardana A, et al. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: Generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine. 1999;10:137-44.
40. Novotny J, Handschumacher M, Haber E, Bruccoleri RE, Carlson WB, Fanning DW, et al. Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc Natl Acad Sci USA. 1986;83:226-30.
41. Charlesworth MC, Bergert ER, Morris JC, McCormick DJ, Ryan RJ. The antigenic structure of the human glycoprotein hormone alpha-subunit: Iii Solution- and solid-phase mapping using synthetic peptides. Endocrinology. 1991;128:2907-15.
42. Jackson AM, Klonisch T, Lapthorn AJ, Berger P, Isaacs NW, Delves PJ, et al. Identification and selective destruction of shared epitopes in human chorionic gonadotropin beta subunit. J Reprod Immunol. 1996;31:21-36.
43. Charrel-Dennis M, Jackson AM, Lund T, Lapthorn AJ, Berger P, Roitt IM, et al. The major hormone-specific discontinuous epitopes on human chorionic gonadotrophin. J Mol Endocrinol. 2004;32:571-81.
44. Deshmukh US, Pal R, Talwar GP, Gupta SK. Antibody response against epitopes on hCG mapped by monoclonal antibodies in women immunized with an anti-hCG vaccine and its implications for bioneutralization. J Reprod Immunol. 1993;25:103-17.
45. Novotny J, Bruccoleri R, Newell J, Murphy D, Haber E, Karplus M. Molecular anatomy of the antibody binding site. J Biol Chem. 1983;258:14433-7.
46. Atassi MZ, Smith JA. A proposal for the nomenclature of antigenic sites in peptides and proteins. Immunochemistry. 1978;15:609-10.
47. Wu H, Lustbader JW, Liu Y, Canfield RE, Hendrickson WA. Structure of human chorionic gonadotropin at 2.6 a resolution from mad analysis of the selenomethionyl protein. Structure. 1994;2:545-58.
48. Schwarz S, Krude H, Klieber R, Dirnhofer S, Lottersberger C, Merz WE, et al. Number and topography of epitopes of human chorionic gonadotropin (hCG) are shared by desialylated and deglycosylated hCG. Mol Cell Endocrinol. 1991;80:33-40.
49. Birken S, Kovalevskaya G, O'Connor J. Metabolism of hCG and hLH to multiple urinary forms. Mol Cell Endocrinol. 1996;125:121-31.
50. Kovalevskaya G, Birken S, Kakuma T, O'Connor JF. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J Endocrinol. 1999;161:99-106.
51. Birken S, Yershova O, Myers RV, Bernard MP, Moyle W. Analysis of human choriogonadotropin core 2 o-glycan isoforms. Mol Cell Endocrinol. 2003;204:21-30.
52. Cole LA, Sutton JM, Higgins TN, Cembrowski GS. Between-method variation in human chorionic gonadotropin test results. Clin Chem. 2004;50:874-82.
53. Birken S, Armstrong EG, Kolks MA, Cole LA, Agosto GM, Krichevsky A, et al. Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology. 1988;123:572-83.
54. Berger P, Sturgeon C. Human chorionic gonadotropin isoforms and their epitopes: diagnostic utility in pregnancy and cancer. Expert OpinMedDiagn. 2008;2:1347-64.
55. Dirnhofer S, Klieber R, De Leeuw R, Bidart JM, Merz WE, Wick G, et al. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the who birth control vaccine. FASEB J. 1993;7:1381-5.
56. Hoermann R, Berger P, Spoettl G, Gillesberger F, Kardana A, Cole LA, et al. Immunological recognition and clinical significance of nicked human chorionic gonadotropin in testicular cancer. Clin Chem. 1994;40:2306-12.
57. Grenache DG, Greene DN, Dighe AS, Fantz CR, Hoefner D, McCudden C, et al. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays. Clin Chem. 2010;56:1839-44.
58. Madersbacher S, Berger P, Mann K, Kuzmists R, Wick G. Diagnostic value of free subunits of serum chorionic gonadotropin in testicular cancer. Lancet. 1990;336:630-1.
59. Lempiainen A, Stenman UH, Blomqvist C, Hotakainen K. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer. Clin Chem. 2008;54:1840-3.
60. Stenman UH, Tiitinen A, Alfthan H, Valmu L. The classification, functions and clinical use of different isoforms of hCG. Hum Reprod Update. 2006;12:769-84.
61. Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, et al. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res. 1992;52:3901-7.
62. Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 1992;52:4628-33.
63. Alfthan H, Stenman UH. Pregnancy serum contains the beta-core fragment of human choriogonadotropin. J Clin Endocrinol Metab. 1990;70:783-7.
64. Norman RJ, Buck RH, Aktar B, Mayet N, Moodley J. Detection of a small molecular species of human chorionic gonadotropin in the urine of patients with carcinoma of the cervix and cervical intraepithelial neoplasia: comparison with other assays for human chorionic gonadotropin and its fragments. Gynecol Oncol. 1990;37:254-9.
65. O'Connor JF, Schlatterer JP, Birken S, Krichevsky A, Armstrong EG, McMahon D, et al. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies. Cancer Res. 1988;48:1361-6.
66. Schwarz S, Berger P, Wick G. Epitope-selective, monoclonal-antibody-based immunoradiometric assays of predictable specificity for differential measurement of choriogonadotropin and its subunits. Clin Chem. 1985;31:1322-8.
67. Klonisch T, Panayotou G, Edwards P, Jackson AM, Berger P, Delves PJ, et al. Enhancement in antigen binding by a combination of synergy and antibody capture. Immunology. 1996;89:165-71.
68. Stenman UH, Alfthan H, Ranta T, Vartiainen E, Jalkanen J, Seppala M. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids. J Clin Endocrinol Metab. 1987;64:730-6.
69. Madersbacher S, Klieber R, Mann K, Marth C, Tabarelli M, Wick G, et al. Free alpha-subunit, free beta-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin Chem. 1992;38:370-6.
70. Lempiainen A, Hotakainen K, Blomqvist C, Alfthan H, Stenman UH. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients. Clin Chem. 2012;58:1123-9.
71. Klonisch T, Delves PJ, Berger P, Panayotou G, Lapthorn AJ, Isaacs NW, et al. Relative location of epitopes involved in synergistic antibody binding using human chorionic gonadotropin as a model. Eur J Immunol. 1996;26:1897-905.
72. Charrel-Dennis M, Terrazzini N, McBride JD, Kaye P, Martensen PM, Justesen J, et al. The human chorionic gonadotropin-beta arginine68 to glutamic acid substitution fixes the conformation of the c-terminal peptide. Mol Endocrinol. 2005;19:1803-11.